Group 1 - Glyphosate concept stocks increased by 2.03%, ranking 4th among concept sectors, with 15 stocks rising, led by Jiangtian Chemical, Yangnong Chemical, and Yingtai Biological, which rose by 10.47%, 5.33%, and 3.40% respectively [1] - The main funds net inflow into the glyphosate concept sector was 47 million yuan, with 8 stocks receiving net inflows, and 5 stocks seeing inflows exceeding 10 million yuan, led by Noposion with a net inflow of 38.12 million yuan [2] - The top three stocks by net inflow ratio were Taihe Co., Ltd., Lier Chemical, and Noposion, with net inflow ratios of 8.33%, 5.80%, and 5.40% respectively [3] Group 2 - The glyphosate concept stocks' performance included Noposion with a 2.61% increase, Jiangtian Chemical with a 10.47% increase, and Lier Chemical with a 2.12% increase, among others [3] - The overall market performance showed that the glyphosate concept was among the top gainers, indicating positive market sentiment towards this sector [2]

证券代码： 000553(200553) 证券简称： 安道麦 A(B) 公告编号： 2025-27 号 2025 年 2 月，一名自然人（以下简称"原告""上诉人"）以证券虚假陈述责任 为由对中国化工集团有限公司（被告一、被上诉人一）、先正达集团股份有限公 司（被告二、被上诉人二）及公司（被告三、被上诉人二）提起诉讼（以下简称 "本次诉讼"）。原告诉称，其基于对公司及股东（被告一、被告二）履行承诺义 务及信息披露义务的信赖，对公司股票进行了长期投资，被告一及被告二未按照 《深交所重组问询函回复公告》《沙隆达重组报告书》及《安道麦收购报告书》 等文件中记载的承诺事项履行义务，包括未解决同业竞争问题、未按承诺的履约 方式和时限履行义务等；公司在深圳证券交易所互动易平台发布的信息（即，沙 隆达重组报告书包含的履约能力分析不属于中国化工集团的具体承诺事项）与承 诺事项不符，构成虚假陈述及误导性陈述，并且公司未履行信息披露责任。原告 安道麦股份有限公司 关于自愿披露公司涉及诉讼的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.案件所处的诉讼阶段 ...

Group 1 - The company will hold a 2025 semi-annual online performance briefing on August 27, 2025, from 3:00 PM to 4:00 PM [1] - The meeting will primarily be conducted in English with simultaneous translation available in Chinese [2] - Key company representatives attending the briefing include CEO Gaël Hili, CFO Efrat Nagar, CBO Eric Dereudre, Global Investor Relations Head Joshua Phillipson, and Board Secretary Guo Zhi [3] Group 2 - Investors can participate in the online performance roadshow through various platforms, including Tonghuashun and Zhito Finance [4] - The briefing will consist of a performance introduction and a Q&A session, allowing investors to submit questions via email or during the meeting [5] - The announcement was made by the company's board on August 19, 2025 [7]

资金流向方面，8月18日主力资金净流出3.72万元，近五日主力资金净流入298.94万元。 风险提示：市场有风险，投资需谨慎。 安道麦A主营业务为农药及植保制剂的生产与销售，产品主要应用于农业种植领域。公司是全球领先的 植保企业之一，拥有丰富的登记证储备。 消息面上，安道麦A宣布将于2025年8月27日举行半年度网上业绩说明会。此外，公司在互动平台回应 投资者提问时表示，财务业绩真实反映经营情况，不存在对大股东利益输送的行为。截至2025年8月8 日，公司A股股东人数为25，725户。 截至2025年8月18日15时，安道麦A股价报6.86元，与前一交易日持平。当日开盘价为6.89元，最高触及 6.91元，最低下探6.80元，成交量为6.16万手，成交额0.42亿元。 ...

Core Viewpoint - Company announced an online performance briefing for the first half of 2025 scheduled for August 27, 2025, from 3:00 PM to 4:00 PM [2] Group 1 - Company is set to hold a performance briefing to discuss its financial results for the first half of 2025 [2] - The event will take place online, indicating a focus on accessibility for stakeholders [2] - The timing of the briefing is strategically planned for a Wednesday afternoon, which may facilitate attendance [2]

Core Viewpoint - The company, Andermatt A (000553), primarily focuses on the application of its plant protection products in the agricultural planting sector within the domestic market [1] Summary by Relevant Categories Company Information - Andermatt A has confirmed through investor interactions that its current plant protection formulations are mainly utilized in the agricultural planting field [1]

Group 1 - The company's financial performance objectively and accurately reflects the industry market environment and the results of its operations [2] - The company denies any situation of profit transfer to major shareholders [2]

证券日报网讯安道麦A8月18日在互动平台回答投资者提问时表示，公司此前发布新闻的创新化合物 GilboaTM（氟磺菌酮，flumetylsulforim）属于农业领域的创新药。GilboaTM经杀菌剂抗性管理行动委 员会（Fungicide Resistance Action Committee）认证为全新谷物杀菌作用机制。 （文章来源：证券日报） ...

Group 1 - The company, as a global leader in the crop protection industry, has a rich reserve of registration certificates [2] - The company expresses its commitment to actively respond to government requirements and contribute to the healthy and sustainable development of the pesticide industry [2]

Core Viewpoint - As of August 8, 2025, the number of A-share shareholders for the company is reported to be 25,725 [1] Company Summary - The company, Andon Health A (000553), provided an update on its A-share shareholder count in response to investor inquiries on August 18 [1]